Industry Focus
Healthcare: MannKind's Back from the Brink
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:27:32
- Mais informações
Informações:
Sinopse
A new cash lifeline from United Therapeutics buys the diabetes drugmaker more time to increase sales of its inhaled insulin. Also, make-or-break news is fast approaching for cardiovascular drugmaker, Amarin. MNKD, UTHR, AMRN
